KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Goodwill (2016 - 2023)

Emergent BioSolutions (EBS) has 13 years of Goodwill data on record, last reported at $218.2 million in Q4 2022.

  • For Q4 2022, Goodwill fell 2.98% year-over-year to $218.2 million; the TTM value through Dec 2022 reached $218.2 million, down 2.98%, while the annual FY2022 figure was $218.2 million, 2.98% down from the prior year.
  • Goodwill reached $218.2 million in Q4 2022 per EBS's latest filing, down from $224.9 million in the prior quarter.
  • Across five years, Goodwill topped out at $268.3 million in Q2 2019 and bottomed at $49.1 million in Q1 2018.
  • Average Goodwill over 5 years is $191.8 million, with a median of $242.3 million recorded in 2018.
  • Peak YoY movement for Goodwill: surged 446.1% in 2019, then dropped 15.67% in 2021.
  • A 5-year view of Goodwill shows it stood at $259.7 million in 2018, then grew by 2.66% to $266.6 million in 2019, then grew by 0.04% to $266.7 million in 2020, then decreased by 15.67% to $224.9 million in 2021, then dropped by 2.98% to $218.2 million in 2022.
  • Per Business Quant database, its latest 3 readings for Goodwill were $218.2 million in Q4 2022, $224.9 million in Q4 2021, and $266.5 million in Q1 2021.